Physician profile
Ellis Tavin
NPI 1326003179
$4,046.33
in general payments reported to CMS, 2019-2025
21 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what 77% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $472 · 2021: $255 · 2022: $646 · 2023: $310 · 2024: $543 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595 · Travel and Lodging: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.83 |
| Travel and Lodging | $517.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,172.20 | 2023-2025 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $860.42 | 2019-2022 | |
| Organogenesis INC. | $309.24 | 2020-2025 | Via Matrix, Puraply Wound Matrix |
| Allergan, INC. | $301.07 | 2019-2022 | |
| Smith+Nephew, INC. | $189.96 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Motiva USA, LLC | $184.40 | 2024-2025 | |
| Mentor Worldwide LLC | $179.73 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Innovation Technologies INC | $141.01 | 2023-2025 | Irrisept |
| Acera Surgical, INC. | $137.54 | 2019-2024 | Restrata Wound Matrix |
| Tela Bio, INC. | $100.63 | 2021-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Integra Lifesciences Corporation | $87.18 | 2022-2025 | Integra, Omnigraft, Surgimend |
| Musculoskeletal Transplant Foundation INC. | $78.08 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $73.47 | 2023-2024 | Exparel |
| Kci USA, INC. | $70.38 | 2019-2022 | |
| Stryker Corporation | $59.79 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $24.79 | 2025 | Prevena, V.A.C.Ulta |
| Davol INC. | $24.68 | 2024 | Arista Ah Flexitip |
| Sanara Medtech INC. | $15.32 | 2024 | Celleraterx |
| Acell, INC. | $13.46 | 2019 | |
| Medline Industries LP | $13.11 | 2022 | |
| Medela LLC | $9.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellis Tavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.